Health Care News

Yahoo! Finance Feb 01, 2023 06:00 AM ET

1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell

MRNA $176.06 (-2.66%)

Yahoo! Finance Feb 01, 2023 06:00 AM ET

IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology Conference

IDYA $17.03 (2.84%)

Yahoo! Finance Feb 01, 2023 05:56 AM ET

Even after rising 19% this past week, AquaBounty Technologies (NASDAQ:AQB) shareholders are still down 54% over the past five years

AQB $1.17 (2.63%)

Yahoo! Finance Feb 01, 2023 05:30 AM ET

Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth

GLSI $19.84 (2.06%)

Yahoo! Finance Feb 01, 2023 05:26 AM ET

2 Top Dividend Growth Stocks to Buy in February

CVS $88.22 (1.34%), ABT $110.55 (0.67%)

Yahoo! Finance Feb 01, 2023 05:22 AM ET

Premier (NASDAQ:PINC) Has Announced A Dividend Of $0.21

PINC $33.36 (0.97%)

Yahoo! Finance Feb 01, 2023 05:11 AM ET

Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while institutions account for 35%

PRQR $2.76 (1.85%)

Yahoo! Finance Feb 01, 2023 05:05 AM ET

Teladoc Health (NYSE:TDOC) adds US$377m to market cap in the past 7 days, though investors from three years ago are still down 73%

TDOC $29.40 (5.57%)

Yahoo! Finance Feb 01, 2023 05:00 AM ET

DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call

DVA $82.39 (1.84%)

Yahoo! Finance Feb 01, 2023 04:34 AM ET

FTSE 100: GSK tops forecasts after strong sales of shingles vaccine

GSK $35.26 (0.40%)

Yahoo! Finance Feb 01, 2023 04:24 AM ET

Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics

AMGN $252.40 (0.32%)

Yahoo! Finance Feb 01, 2023 04:02 AM ET

Edwards Lifesciences (EW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

EW $76.70 (0.84%)

Yahoo! Finance Feb 01, 2023 03:54 AM ET

Pfizer (PFE) Reports Q4 Earnings: What Key Metrics Have to Say

PFE $44.16 (1.40%)

Yahoo! Finance Feb 01, 2023 03:40 AM ET

FTSE 100 Live: Vodafone revenues fall in Europe, GSK profits rise

GSK $35.26 (0.40%)

Yahoo! Finance Feb 01, 2023 03:28 AM ET

Meridian Bioscience finalizes $1.53B sale to South Korean-based firms

VIVO $33.97 (0.00%)

Yahoo! Finance Feb 01, 2023 03:16 AM ET

Stocks to Watch in Europe: GSK, Novartis, Novo Nordisk, BBVA, Entain

NVS $90.62 (1.09%)

Yahoo! Finance Feb 01, 2023 02:25 AM ET

Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts

NVO $138.78 (-0.20%)

Yahoo! Finance Feb 01, 2023 01:46 AM ET

UPDATE 2-Novo Nordisk launches 'strong' guidance, warns of supply constraints

NVO $138.78 (-0.20%)

Yahoo! Finance Feb 01, 2023 01:32 AM ET

UPDATE 2-Novartis says operating profit to grow again ahead of Sandoz spin off

NVS $90.62 (1.09%)

Yahoo! Finance Feb 01, 2023 01:30 AM ET

Novo Nordisk's sales increased by 26% in Danish kroner and by 16% at constant exchange rates to DKK 177.0 billion in 2022

NVO $138.78 (-0.20%)

Yahoo! Finance Feb 01, 2023 01:00 AM ET

Novartis continues to grow with further core margin expansion and achieves important innovation milestones

NVS $90.62 (1.09%)

Yahoo! Finance Jan 31, 2023 11:23 PM ET

Koninklijke Philips Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

PHG $17.12 (-4.84%)

Yahoo! Finance Jan 31, 2023 09:26 PM ET

Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering

ITGR $65.81 (-6.97%)

Yahoo! Finance Jan 31, 2023 08:40 PM ET

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ACET $9.15 (5.17%)

Yahoo! Finance Jan 31, 2023 07:00 PM ET

Pfizer (PFE) Q4 2022 Earnings Call Transcript

PFE $44.16 (1.40%)

Yahoo! Finance Jan 31, 2023 06:43 PM ET

CORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BLCM $1.14 (-2.56%)

$Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)$

Yahoo! Finance Jan 31, 2023 06:30 PM ET

Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)

MESO $3.30 (-0.30%)

Yahoo! Finance Jan 31, 2023 06:20 PM ET

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT $124.97 (3.40%)

Yahoo! Finance Jan 31, 2023 06:10 PM ET

Pfizer Can't Catch a Break, but Investors Can

PFE $44.16 (1.40%)

Yahoo! Finance Jan 31, 2023 06:08 PM ET

Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.

PFE $44.16 (1.40%)

Yahoo! Finance Jan 31, 2023 05:46 PM ET

Edwards Expects 2023 Sales To Outperform The 'Challenging Environment'

EW $76.70 (0.84%)

Yahoo! Finance Jan 31, 2023 05:43 PM ET

Bank of America Expects Small Caps to Beat Large Caps in 2023 — Here Are 2 Stocks That Wall Street Likes

KURA $13.82 (4.94%), RAPT $29.05 (7.75%)

Yahoo! Finance Jan 31, 2023 05:30 PM ET

HEXO Announces Election of Directors

HEXO $1.60 (1.91%)

Yahoo! Finance Jan 31, 2023 05:19 PM ET

There's A Key Element Missing From Amgen's 2023 Outlook, Making Comparisons 'Messy'

AMGN $252.40 (0.32%)

Yahoo! Finance Jan 31, 2023 05:00 PM ET

Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site

TIL $0.81 (3.03%)

Yahoo! Finance Jan 31, 2023 05:00 PM ET

Evolent Health, Inc. to Release Fourth Quarter Financial Results and Host Conference Call on Wednesday, February 22, 2023

EVH $32.22 (2.09%)

Yahoo! Finance Jan 31, 2023 05:00 PM ET

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

CEMI $0.36 (1.32%)

Yahoo! Finance Jan 31, 2023 04:44 PM ET

Amgen’s Q4 tops views, but 2023 guidance falls on lower end of expectations

AMGN $252.40 (0.32%)

Yahoo! Finance Jan 31, 2023 04:38 PM ET

UPDATE 1-Amgen revenue falls slightly as Lilly COVID deal contributes less

LLY $344.15 (1.07%), AMGN $252.40 (0.32%)

Yahoo! Finance Jan 31, 2023 04:36 PM ET

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BLCM $1.14 (-2.56%)

Yahoo! Finance Jan 31, 2023 04:22 PM ET

J&J Faces Longer Path to Resolving Talc Lawsuits After Appeals Court Defeat

JNJ $163.42 (0.88%)

Yahoo! Finance Jan 31, 2023 04:20 PM ET

Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views

EW $76.70 (0.84%)

Yahoo! Finance Jan 31, 2023 04:15 PM ET

EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

EW $76.70 (0.84%)

Yahoo! Finance Jan 31, 2023 04:15 PM ET

Dynavax Announces Uplisting to the Nasdaq Global Select Market

DVAX $11.38 (-0.26%)

Yahoo! Finance Jan 31, 2023 04:15 PM ET